Preincubation with receptor agonists or phorbol esters desensitized muscarinic-receptor-mediated [3H]cyclic GMP responses in mouse neuroblastoma N1E-1 15 cells. However, desensitization mediated by phorbol esters was heterologous, whereas that effected by receptor agonist was specific towards the muscarinic receptors. In addition, there was no loss of cell surface muscarinic receptors, as measured by the binding of the hydrophilic ligand [3H]N-methylscopolamine, when cells were treated with phorbol esters, but receptor-agonist-induced desensitization was accompanied by a decrease in cell surface receptor density. We examined the role of protein kinase C (PKC) in the desensitization of muscarinic receptors by employing a kinase inhibitor and by down-regulation of PKC by long-term incubation of cells with phorbol esters. Whereas these manoeuvres had marked effects on phorbol-ester-induced desensitization of muscarinic responses, they did not block agonist-induced down-regulation and desensitization of muscarinic receptors. In addition, when phosphoinositide hydrolysis was suppressed, the muscarinic agonist was still capable of mediating receptor sequestration and desensitization. These results suggest that the mechanisms for regulating muscarinic receptor sensitivity could be both PKC-dependent and PKC-independent, being mediated by phorbol esters and receptor agonists respectively. INTRODUCTION Muscarinic receptors, like many other receptor systems, are susceptible to agonist-induced desensitization. Thus prolonged interaction between agonists and muscarinic receptors results in desensitization of the receptor-mediated increases in cyclic GMP formation [1] [2] [3] , phosphoinositide (Pl) hydrolysis [4] [5] [6] and intracellular Ca2+ [4, 7] , and inhibition of adenylate cyclase [8] .
INTRODUCTION
Muscarinic receptors, like many other receptor systems, are susceptible to agonist-induced desensitization. Thus prolonged interaction between agonists and muscarinic receptors results in desensitization of the receptor-mediated increases in cyclic GMP formation [1] [2] [3] , phosphoinositide (Pl) hydrolysis [4] [5] [6] and intracellular Ca2+ [4, 7] , and inhibition of adenylate cyclase [8] .
Although the precise molecular and biochemical events underlying muscarinic receptor desensitization remain unclear, it has been shown that a good correlation exists between the relative efficacy of a series of muscarinic agonists for stimulation of PI breakdown and their effectiveness in inducing receptor sequestration [9] and desensitization of receptor-mediated electrophysiological responses [10] . The breakdown of phosphatidylinositol bisphosphate upon stimulation of a variety of neurotransmitter receptors generates diacylglycerol (DAG) [11] , an endogenous activator of protein kinase C (PKC) [12] . The tumour-promoting phorbol esters activate PKC by substituting for the endogenous DAG in a variety of tissues [13] , and they have been useful in studying the role of this kinase in cell regulation. There are numerous examples where phorbol esters induce a decrease in the accumulation of inositol phosphates [14- 171 and cyclic GMP [18] in response to muscarinic agonists.
Therefore involvement of PKC has been implicated in desensitization of muscarinic receptors [19, 201 , representing a negative feedback control in response to increased PI breakdown (for discussion, see [21] ).
In the light of this hypothesis, the goal of the present study was to rigorously assess the role of PKC in desensitization of muscarinic receptors induced by either receptor agonists or phorbol esters using the widely studied murine neuroblastoma NIE-115 cell line [22] . The muscarinic-receptor-mediated responses we have chosen to monitor are cyclic GMP formation and PI hydrolysis. These two responses are mediated by the same muscarinic receptor subtype (M1) in NlE-1 15 cells, as defined pharmacologically by the use of the novel antagonist pirenzepine [23, 24] . In addition, both are susceptible to desensitization by phorbol esters and receptor agonists [18, 25, 26] . The major finding is that there appear to be two distinct and independent pathways underlying muscarinic receptor desensitization in N1E- 1 were terminated by filtration as described [18, 25] .
13HlCyclic GMP measurements
Relative changes in cyclic GMP formation in intact cells were measured as described [26] . Briefly, cells were collected by incubation with 10 ml of Puck's D1 solution [27] 10 #g of phosphatidylserine and 4 jig of dioleoylglycerol (all from Sigma).
After 3 min at 37°C, the reaction was stopped by adding 1 ml of cold 1 M-NaH2PO4 in 20 % trichloroacetic acid, and the reaction mixture was filtered through a GF/C filter, washed with 2 x 3 ml of 1 M-NaH2PO4 in 10% trichloroacetic acid and counted for radioactivity by liquid scintillation spectrometry. The Ca2+-and phospholipid-dependent phosphorylation was determined by subtracting the amount of 32P incorporated under the basal conditions from that in the presence of phospholipid and Ca2 . In the absence of phospholipid, the amount of 32P incorporated with the addition or omission of Ca2+ were the same (results not shown); therefore it is unlikely that other Ca2+-dependent protein kinases contributed to 32P incorporation into the histone when both phospholipid and Ca2+ were present. [29] , using y-globulin as standard.
RESULTS

Characteristics of desensitization induced by muscariic agonists and phorbol esters
After NlE-1 15 cells were treated with the muscarinic receptor agonist CBC (1 mM) for 30 min and then washed, the cyclic GMP formation stimulated by a second addition of CBC was reduced to 12.5 + 0.8 % of that in control cells. A similar refractoriness of the cyclic GMP response to CBC (18.2 + 3.9 % of control) was observed after the cells were exposed to 100 nm-PMA for 60 min (results not shown). CBC-induced desensitization was specific toward the muscarinic receptors as CBC pretreatment caused only a slight desensitization of the histamine-mediated cyclic GMP response (results not shown). However, desensitization induced by PMA was heterologous, since preincubation of the cells with PMA also desensitized histamine-H1-receptor-mediated (Fig. 3) . Moreover, incubation of cells for 45 min with 20 4uM-phorbol diacetate (PDAc), a readily washable phorbol ester, suppressed agonist-mediated inositol phosphate accumulation to approx. 10% of that in the control (Fig. 4 , inset, assayed as described previously [25] ), and agonist-induced were not pretreated with PDAc (Fig. 4) .
The kinase inhibitor H-7 attenuates PMA-induced desensitization of the CBC-mediated response but fails to prevent muscarinic-agonist-induced desensitization
The enzymic activity of PKC was inhibited by H-7 in a concentration-dependent manner in N 1 E-115 cells, with an IC50 of 15 1tM (results not shown). The inhibitory effect of PMA on CBC-induced cyclic GMP formation in these cells was also reduced significantly by H-7 (Fig. 5) ,"<6 decreased to 12.4+ 1.5 % ofcontrol after 24 h ofPDBu treatment (Fig. 6, inset) . The basal PKC activity present in the same preparations was not significantly changed upon long-term phorbol ester incubation. It is noteworthy that after incubation of the cells with PDBu for 24 h, there was no detectable increase in Ca2+-and phospholipid-independent kinase activity as assayed using the 400 mM-NaCl eluate from DE-52 columns (results not shown). Under these conditions, CBC-mediated cyclic GMP formation was 76 +6.9 % of that in cells not treated with PDBu (results not shown). After the cells had been incubated with 1 ,UMPDBu for 24 h, then washed free of PDBu and reincubated with increasing concentrations of PMA for 1 h, it was found that the inhibitory effect of PMA on CBC-mediated cyclic GMP formation was almost lost, except with very high concentrations of the phorbol ester (Fig. 7a) . In comparison with this, when PKCdown-regulated cells were incubated with increasing concentrations of CBC for 30 min, an agonist-concentration-dependent desensitization of subsequent CBC-induced cyclic GMP form- ation was observed, in the same fashion and to the same extent as in untreated cells (Fig. 7b) . Furthermore, incubation of PKCdown-regulated cells with 1 mM-CBC induced desensitization of the subsequent CBC-mediated cyclic GMP response with a time course that was essentially identical with that in cells which were not treated with PDBu (Fig. 8a) (Fig. 8b) . Thus it appears that CBC-induced down-regulation of muscarinic receptors is independent of PKC.
DISCUSSION
It is well documented that exposure of N1E-1 15 cells to PKCactivating phorbol esters [18, 25, 32] or receptor agonists [1] [2] [3] 33, 34] results in desensitization of muscarinic-agonistmediated responses. The results reported here provide strong evidence that, although the effects ofphorbol esters on muscarinic receptor sensitivity are mediated by PKC, this kinase is not involved in the desensitizing effects of receptor agonists.
The diminished cellular cyclic GMP response resulting from prolonged incubation of NlE-1 15 cells with CBC, but not with phorbol esters, is accompanied by an apparent internalization of muscarinic receptors as demonstrated by the diminished binding of the hydrophilic ligand [3H]NMS. This lack of effect of phorbol esters was despite the observation that, during these treatment periods, PKC activity translocated to the particulate fraction remained elevated, a phenomenon which is considered to be related to PKC activation [35] . Additionally, the presence of the Ca2l ionophore A23187 did not reveal any effect of phorbol esters on [3H]NMS binding, although an increase in intracellular Ca2+ concentration is believed to potentiate the effects of phorbol esters in activating PKC [36] . Thus, from our and others' findings [15] , cell surface muscarinic receptor number does not seem to be affected by PKC activation. However, these results are in disagreement with those reported by other investigators [19] . Furthermore, whereas agonist-induced desensitization was specific towards the muscarinic receptors, that caused by phorbol esters was heterologous, suggestive of different mechanisms of action. This is also supported by the finding that desensitization by both groups of agents was additive.
Under conditions of phorbol ester treatment where CBCmediated accumulation of inositol phosphates was suppressed ( [25, 32] [25] ), similar to findings in other cell types [38] , and resulted in significant attenuation of the inhibition of muscarinic receptor function by phorbol esters. In contrast, PDBu-treated cells were able to undergo muscarinic-agonist-induced desensitization of the cyclic GMP response and receptor down-regulation with a time course and concentration-dependence similar to those observed in untreated cells. Thus these findings support the notion that PKC is involved in the observed actions of phorbol esters, whereas it does not play an important role in receptoragonist-induced desensitization. A dichotomy of mechanisms of desensitization induced by these two classes of agents has been suggested for the,-adrenergic-receptor-adenylate cyclase system in rat glioma C6 cells using a similar approach [39] . However, we cannot exclude the remote possibility that residual PKC activity (10 % of control) might play a role in agonist-induced desensitization. It is noteworthy that this residual enzyme did not represent the Ca2+-and phospholipid-independent form of PKC which is formed by its proteolytic cleavage [40] .
Taken together, several experimental designs presented herein indicate that possible activation of PKC by muscarinic agonists does not play an important role in their ability to desensitize receptor responses. Similarly, recent studies suggest that agonistinduced desensitization of other receptors coupled to PI hydrolysis may be independent of PKC activation [41, 42] . In fact, phorbol esters desensitize the function of other neurotransmitter receptors which are not coupled to PI hydrolysis, e.g. ,J-adrenergic receptors in certain types of cells [39] . Therefore, although the effects of pretreatment of a certain tissue with either a phorbol ester or a receptor agonist on receptor sensitivity might appear similar, these effects might be mediated by different cellular mechanisms.
In summary, we have found that exposure of mouse neuroblastoma NlE-115 cells to phorbol esters resulted in desensitization of the CBC-mediated cyclic GMP response, and this resembled the desensitization induced by preincubation of the cells with a muscarinic receptor agonist, except in being heterologous. It is evident, however, that phorbol-ester-mediated suppression of receptor function is PKC-dependent, whereas agonist-induced desensitization is PKC-independent. Evidence for such divergent mechanisms of muscarinic receptor regulation is severalfold. First, down-regulation of cell surface receptor density occurred upon agonist pretreatment but not phorbol ester incubation. Secondly, receptor agonist was fully capable of inducing down-regulation and desensitization of the muscarinic response under conditions where the PI response was suppressed. Thirdly, a protein kinase inhibitor diminished the effects of phorbol esters without influencing agonist-induced desensitization. Fourthly, although long-term phorbol ester treatment rendered a major loss of the ability of phorbol esters to desensitize the CBC-mediated biochemical response, PKC-depleted cells showed unaltered muscarinic-agonist-mediated receptor desensitization and internalization. Finally, whereas it has been shown that muscarinic-agonist-induced desensitization in cardiac tissue is accompanied by receptor phosphorylation, phorbol ester treatment was ineffective in this respect [43] . In conclusion, alterations in muscarinic receptor sensitivity could be mediated by both PKC-dependent and PKC-independent mechanisms which are triggered by phorbol esters and receptor agonists respectively.
